At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Platinum complexes
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 24 May 2001 Discontinued-Preclinical for Cancer in South Korea (Unknown route)
- 14 Nov 1997 No-Development-Reported for Cancer in South Korea (Unknown route)
- 22 May 1995 New profile